Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors

Type

Conference paper

Publication Date

2018-11-14T00:00:00+00:00

Permalink Close